Search

10 results on this page

Rapidus Bets on 2nm Without Fighting TSMC

Rapidus Bets on 2nm Without Fighting TSMC

Rapidus is pursuing mass production of advanced 2nm semiconductors through a large-scale Japanese national project. Instead of matching TSMC’s scale, the company plans to compete with RUMS, an integrated one-building production model designed for diverse, lower-volume manufacturing.

ITmedia AI+ (日本)Media3h ago#2nm#semiconductors#chip-manufacturing
癌症定制疫苗首度闖過III期

癌症定制疫苗首度闖過III期

Merck與Moderna宣布,個性化腫瘤疫苗intismeran autogene在黑色素瘤III期試驗中取得陽性結果,與PD-1抑制劑聯用可顯著改善無復發生存期及無遠處轉移生存期。該療法利用患者腫瘤突變資料與AI篩選新生抗原,為每位患者製作專屬mRNA疫苗。

虎嗅Media14h ago#cancer-vaccine#neoantigen#mrna
Page 1